| Zacks Company Profile for Revvity Inc. (RVTY : NYSE) |
|
|
| |
| • Company Description |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts.
Number of Employees: 11,000 |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $101.50 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 937,924 shares |
| Shares Outstanding: 117.87 (millions) |
| Market Capitalization: $11,963.77 (millions) |
| Beta: 0.98 |
| 52 Week High: $129.50 |
| 52 Week Low: $87.70 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
8.52% |
3.62% |
| 12 Week |
10.54% |
-6.71% |
| Year To Date |
-9.06% |
-14.55% |
|
|
|
|
| |
| • Address & Contact Information |
| Street Address |
Phone / Fax |
Email Address |
Web URL |
77 4TH AVENUE
-
WALTHAM,MA 02451
USA |
ph: 781-663-6900
fax: 781-663-5985 |
ir@revvity.com |
http://www.revvity.com |
|
|
| |
| • General Corporate Information |
Officers
Prahlad Singh - President and Chief Executive Officer
Maxwell Krakowiak - Senior Vice President and Chief Financial Officer
Anita Gonzales - Vice President and Controller
Peter Barrett - Director
Samuel R. Chapin - Director
|
|
Peer Information
Revvity Inc. (CHCR)
Revvity Inc. (ESRX)
Revvity Inc. (MYDP)
Revvity Inc. (COR)
Revvity Inc. (GBCS)
Revvity Inc. (LAXAF)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 714046109
SIC: 3826
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 07/28/25
|
|
Share - Related Items
Shares Outstanding: 117.87
Most Recent Split Date: 6.00 (2.00:1)
Beta: 0.98
Market Capitalization: $11,963.77 (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 0.28% |
| Current Fiscal Quarter EPS Consensus Estimate: $1.27 |
Indicated Annual Dividend: $0.28 |
| Current Fiscal Year EPS Consensus Estimate: $4.82 |
Payout Ratio: 0.06 |
| Number of Estimates in the Fiscal Year Consensus: 8.00 |
Change In Payout Ratio: 0.01 |
| Estmated Long-Term EPS Growth Rate: 8.23% |
Last Dividend Paid: 04/17/2025 - $0.07 |
| Next EPS Report Date: 07/28/25 |
|
|
|
| |
